AN EXTENSION STUDY TO DEMONSTRATE THE EQUIVALENCE OF LONG-TERM EFFICACY AND SAFETY OF CT-P13 IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO WERE TREATED WITH INFLIXIMAB (REMICADE OR CT-P13) IN STUDY CT-P13 1.1: